The impact of funding cuts on medical research is a pressing concern in today's healthcare landscape, as diminishing financial resources can directly affect the safety of patients involved in clinical trials.With drastic reductions in federal grants, such as those from NIH, researchers struggle to maintain essential oversight provided by Institutional Review Boards (IRBs), which are critical in safeguarding participant rights and ethics in research.